Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 82/100

Q4 2018 Bristol-Myers Squibb Co Earnings Call Transcript

Jan 24, 2019 / 01:30PM GMT
Release Date Price: $49.02 (-1.88%)
Operator

Good day, and welcome to the Bristol-Myers Squibb 2018 Fourth Quarter Results Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.

John E. Elicker
Bristol-Myers Squibb Company - SVP of Corporate Affairs & IR

Thank you, Greg, and good morning, everyone, and thanks for joining the call today. We do have a lot to discuss, including the quarter, our full year results, 2019 outlook as well as some additional perspectives on our announced acquisition of Celgene. We will be using a slide deck today, so we did e-mail it to you about 15 minutes ago. The slides are also available on our website.

Joining me today with prepared remarks are Giovanni Caforio, our Chairman and CEO; Charlie Bancroft, our CFO; and Chris Boerner, our Chief Commercial Officer. Tom Lynch is our Chief Scientific Officer, will also be here for Q&A. You'll see on Slides 2 and 3 of today's presentation our legal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot